These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer]. Guillerme F, Clavier JB, Schumacher C, Falcoz PE, Bourrhala K, Santelmo N, Hassler S, Schott R, Quoix E, Massard G, Noël G. Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043 [Abstract] [Full Text] [Related]
28. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer. Zhao L, West BT, Hayman JA, Lyons S, Cease K, Kong FM. Int J Radiat Oncol Biol Phys; 2007 May 01; 68(1):103-10. PubMed ID: 17363189 [Abstract] [Full Text] [Related]
32. A treatment planning study evaluating a 'simultaneous integrated boost' technique for accelerated radiotherapy of stage III non-small cell lung cancer. Dirkx ML, van Sörnsen De Koste JR, Senan S. Lung Cancer; 2004 Jul 01; 45(1):57-65. PubMed ID: 15196735 [Abstract] [Full Text] [Related]
33. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF, Senan S. Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):348-53. PubMed ID: 22104360 [Abstract] [Full Text] [Related]
34. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases]. Cai Y, Wang WL, Xu B, Zhu GY, Zhang SW. Ai Zheng; 2006 Nov 01; 25(11):1419-22. PubMed ID: 17094913 [Abstract] [Full Text] [Related]
35. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, Sakamoto M, Mitsumori M, Shibuya K, Araki N, Yano S, Hiraoka M. Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1427-31. PubMed ID: 16169670 [Abstract] [Full Text] [Related]
36. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice]. Farzad M, De Luca MC, Rubino G, Pirtoli L, Pepi F, Sebaste L, Ponticelli P, Atzeni G, Maranzano E, Silvano G. Radiol Med; 2001 Dec 01; 102(1-2):72-7. PubMed ID: 11677442 [Abstract] [Full Text] [Related]
37. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis. Macdonald OK, Kruse JJ, Miller JM, Garces YI, Brown PD, Miller RC, Foote RL. Int J Radiat Oncol Biol Phys; 2009 Nov 01; 75(3):950-8. PubMed ID: 19801106 [Abstract] [Full Text] [Related]
38. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. Grills IS, Mangona VS, Welsh R, Chmielewski G, McInerney E, Martin S, Wloch J, Ye H, Kestin LL. J Clin Oncol; 2010 Feb 20; 28(6):928-35. PubMed ID: 20065181 [Abstract] [Full Text] [Related]
39. Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control. Videtic GM, Stephans K, Reddy C, Gajdos S, Kolar M, Clouser E, Djemil T. Int J Radiat Oncol Biol Phys; 2010 Jun 01; 77(2):344-9. PubMed ID: 19765913 [Abstract] [Full Text] [Related]